InvestorsHub Logo
Followers 42
Posts 4850
Boards Moderated 0
Alias Born 08/06/2012

Re: None

Thursday, 08/06/2015 2:38:00 PM

Thursday, August 06, 2015 2:38:00 PM

Post# of 144814
Austrianova had a CGMP in Frankfort Germany for NovaCaps now Cell in a Box. They should have no problem getting another up and running yet it's NOT.

According to Austrianova
"We have the technology and know-how to achieve any type or scale of production within a quick time-frame depending on our customers’ requirements."
http://austrianova.com/manufacturing/

And here

The company also has a GMP compliant production facility in Frankfurt, Germany. Austrianova’s core strategy is to develop proprietary delivery technologies in orphan niche indications in the oncology sector and has developed a unique and versatile cell encapsulation technology that can be applied to a wide range of therapeutic applications. The capsules which show a high mechanical resistance, have adjustable pore sizes and are biocompatible, act both to immunoprotect cells and to restrain them on the site of application whilst allowing them excellent access to nutrients and other factors required for their long term survival in a patient. As of today, Austrianova is the only company worldwide to have an IP protected GMP industrial production line for the encapsulation of living cells in cellulose sulphate. This unique asset will enable the company to rapidly bring its reference clinical product NovaCaps® to market and diversify the commercialisation of its primary delivery technology into other non-orphan indications.

http://www.businesswire.com/news/home/20070605005587/en/AUSTRIANOVA-Completes-Closing-35-EURO-Series-Financing#.VcOmzlI8LCR


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News